BALPHARMAPharmaceuticals
Bal Pharma Ltd — Balance Sheet
₹60.42
-1.51%
Bal Pharma Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 1.59 Cr | 1.58 Cr | 1.57 Cr | 1.56 Cr | — |
| Share Issued | 1.59 Cr | 1.58 Cr | 1.57 Cr | 1.56 Cr | — |
| Net Debt | 148.66 Cr | 135.40 Cr | 129.51 Cr | 102.53 Cr | — |
| Total Debt | 150.41 Cr | 142.25 Cr | 133.08 Cr | 106.66 Cr | — |
| Tangible Book Value | 61.59 Cr | 54.08 Cr | 49.50 Cr | 46.81 Cr | — |
| Invested Capital | 227.83 Cr | 208.89 Cr | 194.79 Cr | 162.27 Cr | — |
| Working Capital | 15.37 Cr | 31.10 Cr | 18.82 Cr | 18.93 Cr | — |
| Net Tangible Assets | 61.59 Cr | 54.08 Cr | 49.50 Cr | 46.81 Cr | — |
| Common Stock Equity | 77.42 Cr | 69.29 Cr | 63.79 Cr | 58.63 Cr | — |
| Total Capitalization | 108.83 Cr | 105.64 Cr | 94.31 Cr | 85.64 Cr | — |
| Total Equity Gross Minority Interest | 77.40 Cr | 69.26 Cr | 63.70 Cr | 58.49 Cr | — |
| Minority Interest | -0.01 Cr | -0.03 Cr | -0.09 Cr | -0.13 Cr | — |
| Stockholders Equity | 77.42 Cr | 69.29 Cr | 63.79 Cr | 58.63 Cr | — |
| Other Equity Interest | 61.49 Cr | 0.67 Cr | 1.39 Cr | 1.85 Cr | — |
| Capital Stock | 15.92 Cr | 15.80 Cr | 15.69 Cr | 14.82 Cr | — |
| Common Stock | 15.92 Cr | 15.80 Cr | 15.69 Cr | 14.82 Cr | — |
| Total Liabilities Net Minority Interest | 258.29 Cr | 250.26 Cr | 249.47 Cr | 202.04 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 38.79 Cr | 47.22 Cr | 40.14 Cr | 36.40 Cr | — |
| Non Current Deferred Taxes Liabilities | 0.00 | 3.96 Cr | 2.87 Cr | 0.60 Cr | — |
| Long Term Debt And Capital Lease Obligation | 31.41 Cr | 37.72 Cr | 31.75 Cr | 29.27 Cr | — |
| Long Term Debt | 31.41 Cr | 36.35 Cr | 30.52 Cr | 27.01 Cr | — |
| Long Term Provisions | 5.64 Cr | 5.09 Cr | 5.07 Cr | 4.69 Cr | — |
| Current Liabilities | 219.50 Cr | 203.04 Cr | 209.33 Cr | 165.64 Cr | — |
| Other Current Liabilities | 6.93 Cr | 4.76 Cr | 5.38 Cr | 3.49 Cr | — |
| Current Debt And Capital Lease Obligation | 119.00 Cr | 104.53 Cr | 101.33 Cr | 77.39 Cr | — |
| Current Debt | 119.00 Cr | 103.25 Cr | 100.48 Cr | 76.63 Cr | — |
| Current Provisions | 1.17 Cr | 0.95 Cr | 0.64 Cr | 0.73 Cr | — |
| Payables | 81.69 Cr | 80.87 Cr | 86.08 Cr | 75.01 Cr | — |
| Total Tax Payable | 0.00 | 2.22 Cr | 6.01 Cr | 4.39 Cr | — |
| Accounts Payable | 81.69 Cr | 77.46 Cr | 78.92 Cr | 65.56 Cr | — |
| Total Assets | 335.69 Cr | 319.53 Cr | 313.17 Cr | 260.53 Cr | — |
| Total Non Current Assets | 100.82 Cr | 85.38 Cr | 85.02 Cr | 75.96 Cr | — |
| Other Non Current Assets | 3.68 Cr | 0.17 Cr | 0.24 Cr | -1000.00 | — |
| Non Current Deferred Taxes Assets | 0.41 Cr | 2.41 Cr | 2.17 Cr | 0.00 | — |
| Investmentin Financial Assets | 7.13 Cr | 0.28 Cr | 1.40 Cr | 1.81 Cr | — |
| Available For Sale Securities | 7.13 Cr | 0.28 Cr | 1.40 Cr | 1.81 Cr | — |
| Goodwill And Other Intangible Assets | 15.82 Cr | 15.21 Cr | 14.29 Cr | 11.82 Cr | — |
| Other Intangible Assets | 12.00 Cr | 11.38 Cr | 10.46 Cr | 7.99 Cr | — |
| Goodwill | 3.83 Cr | 3.83 Cr | 3.83 Cr | 3.83 Cr | — |
| Net PPE | 73.78 Cr | 64.25 Cr | 64.20 Cr | 61.12 Cr | — |
| Gross PPE | 73.78 Cr | 110.11 Cr | 103.36 Cr | 95.80 Cr | — |
| Construction In Progress | 2.79 Cr | 2.65 Cr | 2.02 Cr | 5.54 Cr | — |
| Other Properties | 70.99 Cr | 61.61 Cr | 62.18 Cr | 55.57 Cr | — |
| Current Assets | 234.87 Cr | 234.15 Cr | 228.16 Cr | 184.57 Cr | — |
| Other Current Assets | 25.49 Cr | 0.33 Cr | 0.25 Cr | 0.31 Cr | — |
| Inventory | 103.02 Cr | 87.81 Cr | 98.00 Cr | 74.40 Cr | — |
| Other Receivables | 1.13 Cr | 4.66 Cr | 3.73 Cr | 7.57 Cr | — |
| Taxes Receivable | 0.99 Cr | 0.12 Cr | 0.15 Cr | 0.10 Cr | — |
| Accounts Receivable | 92.44 Cr | 99.62 Cr | 93.98 Cr | 75.31 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 11.80 Cr | 19.93 Cr | 7.46 Cr | 6.08 Cr | — |
| Other Short Term Investments | 10.04 Cr | 15.73 Cr | 5.98 Cr | 4.97 Cr | — |
| Cash And Cash Equivalents | 1.75 Cr | 4.20 Cr | 1.49 Cr | 1.11 Cr | — |
| Capital Lease Obligations | — | 2.65 Cr | 2.08 Cr | 3.02 Cr | 1.92 Cr |
| Retained Earnings | — | 19.34 Cr | 14.69 Cr | 13.58 Cr | 9.45 Cr |
| Additional Paid In Capital | — | 31.29 Cr | 30.18 Cr | 26.68 Cr | 26.68 Cr |
| Other Non Current Liabilities | — | -1000.00 | -1000.00 | -3000.00 | -2000.00 |
| Non Current Pension And Other Postretirement Benefit Plans | — | 5.09 Cr | 5.07 Cr | 4.69 Cr | 4.07 Cr |
| Non Current Deferred Revenue | — | 0.45 Cr | 0.45 Cr | 1.83 Cr | 1.95 Cr |
| Long Term Capital Lease Obligation | — | 1.37 Cr | 1.23 Cr | 2.25 Cr | 1.62 Cr |
| Current Capital Lease Obligation | — | 1.28 Cr | 0.85 Cr | 0.76 Cr | 0.31 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | 0.95 Cr | 0.64 Cr | 0.73 Cr | 0.66 Cr |
| Other Payable | — | 1.07 Cr | 1.00 Cr | 4.88 Cr | 3.78 Cr |
| Dividends Payable | — | 0.12 Cr | 0.15 Cr | 0.17 Cr | 0.19 Cr |
| Non Current Prepaid Assets | — | 2.77 Cr | 2.54 Cr | 1.08 Cr | 1.08 Cr |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Accumulated Depreciation | — | -45.86 Cr | -39.16 Cr | -34.69 Cr | -28.64 Cr |
| Machinery Furniture Equipment | — | 64.39 Cr | 61.31 Cr | 55.81 Cr | 53.91 Cr |
| Buildings And Improvements | — | 28.19 Cr | 25.14 Cr | 26.54 Cr | 24.33 Cr |
| Land And Improvements | — | 14.89 Cr | 14.89 Cr | 7.91 Cr | 7.91 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Cash | — | 0.95 Cr | 1.42 Cr | 1.37 Cr | 1.19 Cr |
| Prepaid Assets | — | 20.85 Cr | 23.32 Cr | 19.53 Cr | 25.64 Cr |
| Other Inventories | — | 5.49 Cr | 5.36 Cr | 4.88 Cr | 4.16 Cr |
| Finished Goods | — | 26.38 Cr | 28.75 Cr | 19.91 Cr | 21.42 Cr |
| Work In Process | — | 30.92 Cr | 27.48 Cr | 18.44 Cr | 12.04 Cr |
| Raw Materials | — | 25.03 Cr | 36.41 Cr | 31.16 Cr | 22.76 Cr |
| Allowance For Doubtful Accounts Receivable | — | -1.66 Cr | -1.46 Cr | -0.91 Cr | -0.75 Cr |
| Gross Accounts Receivable | — | 101.28 Cr | 95.44 Cr | 76.23 Cr | 67.95 Cr |
| Cash Equivalents | — | 0.92 Cr | 0.62 Cr | 0.00 | 0.02 Cr |
| Cash Financial | — | 3.27 Cr | 0.87 Cr | 1.11 Cr | 1.00 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Bal Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.